Vaxcyte
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $468,041,000.
Profit Margin
| 2017 | 0 | -17.23M | |
|---|---|---|---|
| 2018 | 0 | -29.48M | |
| 2019 | 0 | -53.49M | |
| 2020 | 0 | -87.81M | |
| 2021 | 0 | -100.08M | |
| 2022 | 0 | -239.64M | |
| 2023 | 0 | -402.26M |
PCVX Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 75M | 9.19M | 1.8M | 1.40M | 1.23M | 0 | 0 |
Gross profit | -75M | -9.19M | -1.8M | -1.40M | -1.23M | 0 | 0 |
Operating exp. | |||||||
Research and development | 332.34M | 169.45M | 78.41M | 73.56M | 45.60M | 30.14M | 12.78M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 468.04M | 207.33M | 102.08M | 87.10M | 53.91M | 35.53M | 17.40M |
Operating income | -468.04M | -232.25M | -103.67M | -89.58M | -54.15M | -35.53M | -17.83M |
Other income (expenses), net | 65.77M | 8.77M | 3.59M | 364K | 3.87M | 5.22M | 595K |
Income before tax | -402.26M | -223.48M | -100.07M | -89.21M | -50.27M | -29.48M | -17.23M |
Income tax expense | 0 | 16.15M | 7K | -1.39M | 3.22M | 6.12M | 0 |
Net income | -402.26M | -239.64M | -100.08M | -87.81M | -53.49M | -29.48M | -17.23M |
Earnings per share | |||||||
Basic EPS | -4.14 | -3.69 | -1.93 | -1.72 | -1.09 | -1.15 | -4.84 |
Diluted EPS | -4.14 | -3.69 | -1.93 | -1.72 | -1.09 | -1.15 | -4.83 |
| Data source | Data source | Data source | Data source |